Oukejian
Nanshan
About Oukejian
Oukejian specializes in researching and developing innovative large-molecule drugs for prevalent fundus diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $43.6M
- Funding stage: Early Stage Venture
- Last round: Series B (Dec 2025)
- Website: oculgen.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Medical
Canonical: https://fsome.com/organization/oukejian-66334 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.